Peptide targeting and delivery across the blood-brain barrier utilizing synthetic triglyceride esters: design, synthesis, and bioactivity

Bioconjugate Chemistry
D PatelV J Hruby

Abstract

As an approach to the development of therapeutically useful peptide pharmaceuticals that can penetrate the blood-brain barrier, we have designed and demonstrated the application of a carrier-targeting system. We have developed a prodrug design strategy that is designed to utilize membrane-bound enzymes whereby release of a bioactive peptide from a highly lipophilic triglyceride peptide-carrier is achieved in situ, thus attaining high localized concentrations of the bioactive peptide. Following localization of such a system, normal peptidase and lipase action is utilized to release the active peptide (deltorphin II) intact and in high concentration. At present, the exact mechanisms are unclear, but the observed results in which analgesia is observed following peripheral administration suggest that the active peptide is able to cross the blood-brain barrier and sustain prolonged periods of analgesia as determined by antinociception tests by release of the bioactive peptide. In vitro tests of binding and bioactivity by the peptide conjugate show essentially no potency in either target or control analogues, but potent antinociceptive effects are observed following peripheral administration.

References

Jul 1, 1989·Medicinal Research Reviews·V J Hruby, C A Gehrig

❮ Previous
Next ❯

Citations

Oct 16, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·R T Borchardt
Jun 6, 2000·Advanced Drug Delivery Reviews·E M Cornford, S Hyman
Jun 30, 2000·Clinical and Experimental Pharmacology & Physiology·T LockettR Whittaker
Jul 16, 1999·The Journal of Peptide Research : Official Journal of the American Peptide Society·B WangR T Borchardt
Jul 16, 1999·The Journal of Peptide Research : Official Journal of the American Peptide Society·O S GudmundssonR T Borchardt
Dec 1, 2001·Expert Opinion on Biological Therapy·J TemsamaniJ M Scherrmann
Oct 22, 2002·The Journal of Pharmacology and Experimental Therapeutics·Jerry Z YangRonald T Borchardt
Mar 18, 1999·Progress in Neurobiology·L H LazarusS Salvadori
Jul 30, 2010·Chemical Reviews·George R Newkome, Carol Shreiner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.